Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Anebulo Pharmaceuticals Inc
Total Current Assets
Anebulo Pharmaceuticals Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
|
Total Current Assets
$11.7m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Assets
$57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Assets
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Assets
$42.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Assets
$31.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Assets
$25.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Anebulo Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
11.7m
USD
Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Total Current Assets amounts to 11.7m USD.
What is Anebulo Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
57%
Over the last year, the Total Current Assets growth was -25%. The average annual Total Current Assets growth rates for Anebulo Pharmaceuticals Inc have been 57% over the past three years .